Ambassador of New Zealand to the United States, and former WTO Director General, Mike Moore explained today that the Trans Pacific Partnership agreement (TPP) may contain the “sequencing” of intellectual property and other provisions for some members. He made the…
Margot Kaminski (Yale Information Society Project), Brook Baker (Northeastern University) and Jimmy Koo and I (PIJIP) have released a draft section by section analysis of the leaked U.S. proposals for intellectual property and pharmaceutical pricing chapters for the Trans-Pacific Free…
Trans Pacific Partnership negotiators released a “Trade Ministers’ Report to Leaders” at the Asian Pacific Economic Cooperation (APEC) that offered little detail about the status of negotiations. Some observers had expected the report to contain a July 2012 deadline for…
New Zealand is opposing the pharmaceutical provisions tabled by the United States, which would require governments to “appropriately recognize the value of the patented or generic pharmaceutical products or medical devices” when setting reimbursement rates. According to Inside U.S. Trade,…
U.S. Register of Copyrights Maria Pallante has published a report outlining the “Priorities and Special Projects of the U.S. Copyright Office” for the next two years. According to the copyright office press release: “Rogue websites, illegal streaming, small claims, orphan…
By Margot Kaminski, originally posted on Intellectual Property Watch. The role of online intermediaries in copyright enforcement is on the international negotiating table. The topic arose in early drafts of the Anti-Counterfeiting Trade Agreement (ACTA), and has come up again…
Sean Flynn, a lecturer at American University Washington College of Law and Associate Director of its Program on Information Justice and Intellectual Property, testified to negotiators of the Trans Pacific Partnership Agreement in Peru this week that they should reject…
This briefing paper provides preliminary analysis of the leaked U.S. proposal for an intellectual property chapter in the Trans Pacific Partnership (TPP) agreement. What is clear from this analysis is that the U.S. proposal, if adopted, would create the most…
This work is licensed under a Creative Commons Attribution 3.0 Unported License.
For immediate release. By Sean Flynn, sflynn@wcl.american.edu Lima, Peru. Among the US Trans Pacific Partnership (TPP) proposals leaked today was a proposed chapter on “Transparency and Procedural Fairness for Healthcare Technologies,” more widely known as the Pharmaceutical Pricing Chapter. All…
Congressional Democrats, the branded drug industry, and public health groups have commented on USTR’s new approach to intellectual property described in its recently published white paper on trade and access to medicines. Speaking to Inside US Trade, Rep. McDermott said…
The Obama administration’s proposal to reduce U.S. deficits contains two provisions dealing with intellectual property and healthcare. The proposal would reduce data exclusivity for biologic medicines to 7 years (from the current period of 12 years), and would “prohibit additional…